MedTrace Logo

Gene Testing to Help in the Diagnosis and Treatment of Childhood Brain Tumors

NCT00003096 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 88

Last updated 2014-08-06

No results posted yet for this study

Summary

RATIONALE: Analyzing the number and structure of genes found in a child's cancer cells may help doctors improve methods of diagnosing and treating children with brain tumors.

PURPOSE: This clinical trial is studying the number and structure of genes in cancer cells of children with brain tumors.

Conditions

Interventions

GENETIC

DNA ploidy analysis

GENETIC

comparative genomic hybridization

GENETIC

cytogenetic analysis

GENETIC

fluorescence in situ hybridization

Sponsors & Collaborators

  • National Cancer Institute (NCI)

    collaborator NIH

  • Children's Oncology Group

    lead NETWORK

Principal Investigators

  • Jaclyn A. Biegel, PhD · Children's Hospital of Philadelphia

Eligibility

Max Age
20 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
1996-12-31
Primary Completion
2006-03-31
Completion
2007-03-31

Countries

  • United States
  • Australia
  • Canada

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00003096 on ClinicalTrials.gov